Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
AI channel feed
AstraZeneca inks AI drug R&D deal with Chinese pharma for $110M upfront
2 days ago
R&D
China
Watch Post-Hoc Live: What happens when AI thinks in ways we can’t understand?
3 days ago
Editor's note
R&D
Basecamp pitches a fix for AI bio's 'data wall'
4 days ago
Recursion to lay off 20% of staff, a month after slashing its pipeline
5 days ago
People
MIT scientists’ AI model one-ups AlphaFold 3, takes on ‘fundamental issue’ in drug R&D
Last week
Post-Hoc: AI bio needs to heed the overhyped history of CRISPR
4 weeks ago
Pathos AI collects $365M to fuel 'bulletproof' oncology trials and in-license more cancer drugs
5 weeks ago
Financing
Startups
Exclusive: Datavant to acquire real-world data specialist Aetion, doubling life sciences team
Last month
Deals
AI biotech Insilico Medicine goes for third attempt at Hong Kong IPO
Last month
Financing
Startups
AI-focused biotech insitro cuts 22% of staff, citing 'tumultuous market'
Last month
People
Recursion cuts nearly half of its pipeline, including its most advanced program
Last month
R&D
Iambic debuts next version of AI model Enchant, driving new way for drug R&D
Last month
Pathos AI gets AstraZeneca funding as biotech plans to raise up to $400M
Last month
Financing
Startups
FutureHouse debuts AI science agents, inviting skeptical scientists to try for free
Last month
Exclusive: Ex-Calico scientist launches Stately Bio with new way to study cells
Last month
Financing
The Endpoints Slack interview: Arc Institute's Patrick Hsu on investing, AI and new ways of research
Last month
People
Exclusive: Can AI replace animal testing? A new biotech launches to find out
Last month
Financing
Exclusive: BigHat inks Lilly deal for AI-boosted antibodies, extends Series B
Last month
Financing
Exclusive: Charm Therapeutics' founder steps down as CEO, as AI biotech eyes clinic in 2026
Last month
People
Therapy AI chatbot shows promising results: study
2 months ago
Health Tech
Exclusive: Mikael Dolsten shares his post-Pfizer plans, including advising an AI unicorn with pharma dreams
2 months ago
People
Q&A: Demis Hassabis talks 'turbocharging' Isomorphic with $600M, expanding into antibodies and the US
2 months ago
People
Talkspace is using AI to make therapy podcasts for patients
2 months ago
Health Tech
Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025
2 months ago
Financing
Startups
1
2
3
4
Next page
Last page
